Abstract
The Twelfth International Conference on Endothelin (ET-12) was held at Clare College, University of Cambridge, United Kingdom, from September 11–14, 2011, with researchers from basic and clinical science from nearly 20 countries attending. The conference featured a number of invited lectures, presentation of new research in several oral and poster sessions. It also featured newly introduced and well‐received interactive panel discussion reviewing results and challenges of clinical trials using endothelin receptor antagonists conducted in the past 20years. Evidence for new roles of endothelin in physiology and disease was presented, as well as new data from clinical trials in cancer and renal disease suggesting therapeutic efficacy of pharmacological modulation of the endothelin system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
